Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
Daily Nephrology News
Daily Urology News
FDA News
Malpractice News
Industry News
Newsletters
Polls & Surveys
Top 10 2008 Stories
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Urinary Tract Infections
Nephrology
Acute Kidney Injury
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hyperphosphatemia
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Clinical Trials
Acute Kidney Injury
Bladder Cancer
Diabetes Mellitus
Hemodialysis
Hyperphosphatemia
Kidney/Ureteral Stones
Lupus Nephritis
Nephrogenic Systemic Fibrosis
Overactive Bladder
Pelvic Prolapse
Prostate Cancer
Renal Cell Carcinoma
Renal Obstruction
Renal Transplant
Voiding Dysfunction
Commentary
Conferences
Conference Highlights
Meetings Calendar
Renal Week 2008
29th Annual Dialysis Conference
EAU Conference 2009
NKF Spring Meetings
AUA Annual Meeting
ASH Annual Meeting
American Transplant Congress 2009
Canadian Urological Association Annual Meeting
Renal Week 2009
Genitourinary Cancers Symposium
Expert Series
Jobs
Resources
Links
View Full Issue
Features
Cleveland Clinic
World Lit. Review
Legal Issues
Renal Nutrition Update
Your Money
Your Practice
Drug Info
myCME
RSS
|
Login
|
Register
World Literature Review Articles
Pulmonary Hypertension in HD Patients Increases Death Risk
Jody A. Charnow
June 18, 2009
Pulmonary hypertension (PHT) independently predicts greater mortality in hemodialysis (HD) patients, Israeli researchers report.
Hip-Fracture-Related Death Linked to CKD in the Elderly
Jody A. Charnow
June 18, 2009
Among older individuals, an estimated glomerular filtration rate (eGFR) below 45 mL/min/1.73 m2 is associated with a nearly twofold increased risk of hip-fracture-related mortality, according to British researchers.
Intermittent Hormonal Therapy for PCa May Have Benefits
Jody A. Charnow
June 18, 2009
Intermittent hormonal therapy (IHT) for men with locally advanced and metastatic prostate cancer is associated with no reduction in disease progression or survival, according to a European study.
Fatal Infections Probed in Pediatric LN Patients
Jody A. Charnow
May 07, 2009
Prior history of treatment with pulse methylprednisolone may increase the risk of fatal infection in pediatric lupus nephritis (LN) patients treated with IV cyclophosphamide (IVCY), researchers reported.
Pulse Pressure, Death Risk Linked in PD Patients
Jody A. Charnow
May 07, 2009
Elevated pulse pressure is associated with an increased risk of all-cause and cardiovascular death in patients on peritoneal dialysis (PD), according to a Canadian study.
CRP May Predict Survival in Metastatic RCC Patients
Jody A. Charnow
May 07, 2009
Pretreatment C-reactive protein (CRP) levels can be a prognostic marker for patients with metastatic renal cell carcinoma (RCC), a Japanese study suggests.
Sudden Death Risk Factors in Peritoneal Dialysis Patients Identified
Jody A. Charnow
April 02, 2009
Recent blood transfusions, male gender, and diabetes mellitus are independently associated with an increased risk of sudden death in patients on peritoneal dialysis (PD), a Chinese study concluded.
Recovery of Sexual Function After Cryosurgery for PCa
Jody A. Charnow
April 02, 2009
Among prostate cancer patients who had no erectile dysfunction (ED) before undergoing cryosurgery, more than one third recovered full sexual function two years post-operatively, a British study found.
Postlithotripsy Agents Improve Stone Outcomes
Jody A. Charnow
April 02, 2009
Medical expulsive therapy (MET) following shockwave lithotripsy (SWL) results in a significant increase in successful treatment outcomes, according to Canadian researchers.
Alfuzosin Treatment for BPH Improves Sexual Function
Jody A. Charnow
March 17, 2009
Patients who receive alfuzosin as treatment for benign prostatic hyperplasia (BPH) experience improvements in sexual function as well lower urinary tract symptoms (LUTS), a South Korean study suggests.
« Previous
Next »
Most Popular
Most Emailed
Most Recent
Dietary Fat and Prostate Cancer Risk
Glycemic Control in Diabetic ESRD Patients
DASH Diet Variation May Help Lower Blood Pressure
Live Kidney Donation Does Not Shorten Survival
PSM Linked to Obesity in Men with Locally Advanced Prostate Cancer
Chemo May Improve Survival in Men with Advanced PCa on ADT
A doctor referred a man with an elevated PSA level to a urologist, but did not follow-up and ask him if he went
Use of Kidneys From High-Risk Donors Drops
Clinical Trial: A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
Clinical Trial: Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) (SIR)
Drinking Alcohol Raises Prostate Cancer Risk in African Americans
Live Kidney Donation Does Not Shorten Survival
Prostate Cancer Deaths Uncommon Even 30 Years After Surgery
Dietary Fat and Prostate Cancer Risk
Hypogonadism Linked to Statin Use
Novel Drug Prolongs Survival in Men with Metastatic Prostate Cancer
Relief for Haiti's ESRD Patients
Start-Stop Hormone Therapy For Prostate Cancer May Have Benefits
DASH Diet Variation May Help Lower Blood Pressure
Urine Test Accurately Predicts Significant Prostate Cancer
Clinical Trial: Bowel Preparation and Pelvic Organ Prolapse Surgery
Clinical Trial: Pelvic Floor Repair Systems for Prolapse Repair (PROPEL)
Clinical Trial: Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
Clinical Trial: Local Anesthetic Treatments for Overactive Bladder
Clinical Trial: Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Clinical Trial: Caffeine Reduction and Overactive Bladder Symptoms
Clinical Trial: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
Robotic Pyeloplasty Has Advantages
Clinical Trial: Nephrogenic Systemic Fibrosis (NSF): A Chart Review With Analysis of Tissue Gadolinium Levels
Clinical Trial: Immune System Related Kidney Disease
Popular Topics
Acute Kidney Injury
Adrenal Gland
Brachytherapy
Cardiovascular Disease
Chronic Kidney Disease
CKD
Diabetes
End-stage Renal Disease
FSGS
Hemodialysis
Hypertension
Infection
Kidney Cancer
Kidney Disease
Nutrition
Obesity
Prostate Cancer
Prostatitis
PSA
Renal Cell Carcinoma
Renal Masses
Transplantation
Urologic Surgery
Urology
UTI
Sponsored Links